Michael B Sporn

Title: Michael B Sporn: Innovator in Cancer Treatment

Introduction

Michael B Sporn is a notable inventor based in Bethesda, MD (US), recognized for his contributions to cancer treatment. He holds a total of 4 patents, focusing on innovative methods and compositions aimed at preventing and treating various forms of cancer, particularly breast cancer.

Latest Patents

One of his latest patents involves the uses of 9-cis-retinoic acids and derivatives thereof. This invention relates to methods and compositions for preventing or treating cancer, specifically breast cancer. The patent outlines the use of 9-cis-retinoic acid or its derivatives in conjunction with at least one other antineoplastic agent to enhance the effectiveness of cancer treatment. Another significant patent focuses on compositions of transforming growth factor beta (TGF-β), which promotes cell proliferation and tissue repair in animals. This composition includes active ingredients that are activated by either TGF-alpha or EGF, or both, and can be combined with other growth factors for improved efficacy.

Career Highlights

Throughout his career, Michael B Sporn has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the Secretary of Health. His work has significantly impacted the field of oncology, providing new avenues for cancer treatment.

Collaborations

Michael has collaborated with notable colleagues such as Anita B Roberts and Mario A Anzano, contributing to the advancement of cancer research and treatment methodologies.

Conclusion

Michael B Sporn's innovative work in cancer treatment through his patents and collaborations has made a significant impact in the medical field. His dedication to improving cancer therapies continues to inspire future research and development.